{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:14:08Z","timestamp":1773371648582,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T00:00:00Z","timestamp":1336953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Rosacea is a chronic inflammatory dermatosis affecting &gt;2% of the population. Willingness to pay (WTP) is a well established method which reflects the individual burden of disease.<\/jats:p><jats:p><jats:bold>Objectives\u2002<\/jats:bold> Evaluation of WTP and quality of life (QoL) in patients with rosacea.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Nationwide postal survey on adult patients with rosacea affiliated with the German rosacea patient advocacy group. WTP was evaluated by three standardized items and compared to historical data on vitiligo (<jats:italic>n<\/jats:italic>\u2003=\u20031023). QoL was assessed using the Dermatology Life Quality Index (DLQI).<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Data from <jats:italic>n<\/jats:italic>\u2003=\u2003475 rosacea patients (79.9% women, mean age 56.3, range 26\u201390) were analysed. On average, patients were willing to pay \u20ac 2880 (median \u20ac 500) for complete healing compared with \u20ac 7360 (median \u20ac 3000) in vitiligo. Relative WTP was higher in women; the highest sums were registered for the age group 21\u201330\u2003years. The extent of facial involvement predicted a higher relative WTP, whereas WTP decreased with the duration of symptoms and age. Mean DLQI total score was 4.3 compared to 7.0 in vitiligo. In rosacea, the highest values were observed in patients &lt;30\u2003years. Severe QoL reductions (DLQI&gt;10) were less frequent (11%) than in vitiligo (24.6%). The correlation between WTP and DLQI was significant (e.g. <jats:italic>r<\/jats:italic>\u2003=\u20030.249, <jats:italic>P<\/jats:italic>\u2003=\u20030.000 for relative WTP).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Rosacea patients show a moderate WTP and average QoL reduction is mild. WTP proved to be a valid tool to assess patients\u2019 burden of disease. Patient education and the development of effective treatment options might still improve patients\u2019 satisfaction.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2012.04549.x","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T18:31:06Z","timestamp":1337020266000},"page":"734-738","source":"Crossref","is-referenced-by-count":44,"title":["Willingness to pay and quality of life in patients with rosacea"],"prefix":"10.1111","volume":"27","author":[{"given":"F.C.","family":"Beikert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Langenbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,14]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1","article-title":"Prevalence of skin diseases in a population; a census study from the Faroe Islands","volume":"11","author":"Lomholt G","year":"1964","journal-title":"Dan Med Bull"},{"key":"e_1_2_6_3_2","first-page":"419","article-title":"An epidemiological study of rosacea","volume":"69","author":"Berg M","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10436.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042829"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120625"},{"key":"e_1_2_6_7_2","first-page":"73","article-title":"The CLEAR trial: results of a large community\u2010based study of metronidazole gel in rosacea","volume":"79","author":"Wolf JE","year":"2007","journal-title":"Cutis"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1978.tb15214.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2010.09053"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","unstructured":"SuD DrummondPD.Blushing propensity and psychological distress in people with rosacea.Clin Psychol Psychother2011. Jun 23. doi:10.1002\/cpp.763. [Epub ahead of print].","DOI":"10.1002\/cpp.763"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06895.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"Euro Qol\u2010a new facility for the measurement of health related quality of life","volume":"16","author":"The Euro Qol group","year":"1990","journal-title":"Health Policy"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9601600314"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb00930.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03207.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09091.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08354.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07740.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050051056"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23621.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/14764170902741311"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07669.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09894.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03830.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1087-0024.2004.09113.x"},{"key":"e_1_2_6_27_2","first-page":"339","article-title":"A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short\u2010term treatment of stasis dermatitis","volume":"4","author":"Weiss SC","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-4-71"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08236.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05156.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb05019.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200321120-00003"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2012.04549.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2012.04549.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T11:24:42Z","timestamp":1697369082000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2012.04549.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,14]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1111\/j.1468-3083.2012.04549.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04549.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,14]]}}}